Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 15 paź 2021 · Current treatment options for metastatic and locally aggressive BCC are discussed. Basal cell carcinoma (BCC) accounts for 80% of nonmelanoma skin cancers. Classically, these skin lesions develop on sun‐exposed areas of skin, with the head and neck most frequently affected.

  2. 13 lip 2023 · Advanced BCC includes locally advanced BCC (laBCC) and metastatic BCC (mBCC). A retrospective US cohort study reported that laBCC accounts for 0.8% of all BCC cases (age-adjusted incidence rate: 1.83 per 100,000 persons, which is projected to 4399 cases in the US population).

  3. 3 lut 2015 · The treatment of locally advanced BCC, in which surgery or radiotherapy is unfeasible, inappropriate or contraindicated, and metastatic BCC has changed with new Hedgehog pathway inhibitors of which vismodegib is the first drug approved by FDA and EMA.

  4. 15 paź 2021 · The treatment of locally advanced and metastatic BCC presents a significant clinical challenge. Treatment options have evolved recently to include the use of hedgehog inhibitors Vismodigib and Sonidigib and immunotherapy with Cemiplimab.

  5. In advanced stage, BCC exhibits aggressive behavior, leading to local tissue destruction. Thus, a multidisciplinary approach and specialized treatment strategies are required for effective disease management and improvement of the patient quality of life.

  6. 15 paź 2021 · The aim of the present work is to review clinical and pathologic characteristics as well as classical and new treatment options for high-risk, metastatic and locally advanced BCC.

  7. Other risk factors include age, male gender, occupational hazards, radiation, and immunosuppression. BCCs are not typically staged but are instead stratified by their risk of recurring or metastasizing. Locally advanced BCCs are those tumors that are not amenable to surgery or radiation therapy.

  1. Ludzie szukają również